A real-world prospective observational study of eptinezumab in Asian patients with migraine.

Yi Jing ZhaoJonathan Jia Yuan OngSumit Kumar SonuJiaojiao DangChai Ching NgKeira Joann HerrRohini BoseYasmin Idu Jion

Published in: Headache (2024)

Quarterly eptinezumab administration was effective and well-tolerated in Asian patients with chronic migraine.

Keyphrases